Overexpression of IL‐23 in glutamine‐addicted renal carcinoma could enhance the proliferative ability and function of regulatory cells (Tregs) and thus improve the efficacy of PD‐1 blockade.113. The gene discussed is PDCD1; the disease is renal carcinoma.